law of increasing return

Digital

The promise and value of artificial intelligence (AI) in life sciences are somewhat obscured by the over-generalisation of this technology.

News

Astellas takes an option on a cancer immunotherapy developed by Audax for up to $1.34bn, with Gilead and Teva also adding to their pipelines.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.